Literature DB >> 29185430

Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.

Ehsan Ghorani1, Baljeet Kaur2, Rosemary A Fisher3, Dee Short3, Ulrika Joneborg4, Joseph W Carlson5, Ayse Akarca6, Teresa Marafioti6, Sergio A Quezada7, Naveed Sarwar3, Michael J Seckl8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29185430     DOI： 10.1016/S0140-6736(17)32894-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  Human Vaccines & Immunotherapeutics: News.

Authors: 
Journal:  Hum Vaccin Immunother       Date:  2018-01-02       Impact factor: 3.452

Review 2.  Advances in immunotherapy and molecular targeted therapy of gestational trophoblastic tumor: current practice and future perspectives.

Authors:  Suzhu Chen; Taiping Li; Lijuan Meng; Kangsheng Liu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

3.  Effectiveness and Safety of Toripalimab Combination Therapies for Patients With Chemo-Resistant Choriocarcinoma.

Authors:  Xiaomei Liu; Xiuqin Li; Hui Qu; Shiyue Zhang; Ruizhe Zhang; Zhenhua Du
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

4.  Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.

Authors:  Young Sok Ji; Se Hoon Park
Journal:  Cancer Res Treat       Date:  2020-12-07       Impact factor: 4.679

5.  Diagnosis and management of gestational trophoblastic disease: 2021 update.

Authors:  Hextan Y S Ngan; Michael J Seckl; Ross S Berkowitz; Yang Xiang; François Golfier; Paradan K Sekharan; John R Lurain; Leon Massuger
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

Review 6.  Treatment of gestational trophoblastic disease in the 2020s.

Authors:  James J Clark; Susanna Slater; Michael J Seckl
Journal:  Curr Opin Obstet Gynecol       Date:  2021-02-01       Impact factor: 2.211

7.  Next-generation genome sequencing of a matched normal-tumor pair from a patient with intractable gestational choriocarcinoma: A case report.

Authors:  Kaoru Niimi; Eiko Yamamoto; Sachi Morita; Maki Morikawa; Hikaru Hattori; Miki Hatakeyama; Mami Morita; Kimihiro Nishino; Yukari Oda; Eri Watanabe; Toshimichi Yamamoto; Hiroaki Kajiyama; Fumitaka Kikkawa
Journal:  Mol Clin Oncol       Date:  2021-05-23

8.  An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab.

Authors:  Sarah G Bell; Shitanshu Uppal; Michelle D Sakala; Andrew P Sciallis; Aimee Rolston
Journal:  Gynecol Oncol Rep       Date:  2021-06-23

9.  Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report.

Authors:  V Paspalj; S Polterauer; N Poetsch; A Reinthaller; C Grimm; T Bartl
Journal:  Gynecol Oncol Rep       Date:  2021-06-24

Review 10.  Expected advances in human fertility treatments and their likely translational consequences.

Authors:  Norbert Gleicher
Journal:  J Transl Med       Date:  2018-06-04       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.